EWTX270115C00030000
EWTX Jan 15 2027 30.00 Call
optionOPRA
InactiveSep 24, 2026
12.00USD-21.517%(-3.29)1Vol3OI
Loading…
Underlying
Underlying Price
$39.57
Type
Call
Strike
30
Expiration
Jan 15, 2027
DTE
100d
Moneyness
ITM
Intrinsic
$9.57
EWTX 30 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 16, 2026 | 9d | — | — | 0 | 0 |
| Nov 20, 2026 | 44d | $11.70 | +14.26% | 3 | 3 |
| Dec 18, 2026 | 72d | — | — | 0 | 0 |
| Jan 15, 2027 | 100d | $12.00 | -21.52% | 1 | 3 |
| Feb 19, 2027 | 135d | — | — | 0 | 0 |
| Mar 19, 2027 | 163d | $13.00 | +0.00% | 9 | 9 |
| May 21, 2027 | 226d | — | — | 0 | 0 |
EWTX Profile
edgewise therapeutics is a biotechnology company focused on developing novel therapies for diseases involving skeletal muscle. the company is headquartered in boulder, co and received its series a financing from orbimed.